Analyst Price Target is $11.67
▲ +19.90% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for AdaptHealth in the last 3 months. The average price target is $11.67, with a high forecast of $14.00 and a low forecast of $8.00. The average price target represents a 19.90% upside from the last price of $9.73.
Current Consensus is
Moderate Buy
The current consensus among 6 polled investment analysts is to moderate buy stock in AdaptHealth. This rating has held steady since October 2024, when it changed from a Hold consensus rating.
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Read More